3'-HydroxypuerarinCAS# 117060-54-5 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 117060-54-5 | SDF | Download SDF |
PubChem ID | 5748205 | Appearance | White powder |
Formula | C21H20O10 | M.Wt | 432.38 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Synonyms | 3'-Hydroxy Puerarin;117076-54-5;Pueraria Glycoside; 3'-Hydroxypuerarin | ||
Solubility | Soluble in methanol and pyridine | ||
Chemical Name | 3-(3,4-dihydroxyphenyl)-7-hydroxy-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one | ||
SMILES | C1=CC(=C(C=C1C2=COC3=C(C2=O)C=CC(=C3C4C(C(C(C(O4)CO)O)O)O)O)O)O | ||
Standard InChIKey | GARZMRVWLORUSR-VPRICQMDSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 3'-Hydroxypuerarin has antioxidant activity, it shows marked ONOO(-), NO·, total ROS scavenging activities, and weak ·O(2)(-) scavenging activity. |
Targets | NO | NOS | COX | ROS |
In vitro | Anti-inflammatory and antioxidant activities of constituents isolated from Pueraria lobata roots.[Pubmed: 22644850]Arch Pharm Res. 2012 May;35(5):823-37.
|
3'-Hydroxypuerarin Dilution Calculator
3'-Hydroxypuerarin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.3128 mL | 11.5639 mL | 23.1278 mL | 46.2556 mL | 57.8195 mL |
5 mM | 0.4626 mL | 2.3128 mL | 4.6256 mL | 9.2511 mL | 11.5639 mL |
10 mM | 0.2313 mL | 1.1564 mL | 2.3128 mL | 4.6256 mL | 5.782 mL |
50 mM | 0.0463 mL | 0.2313 mL | 0.4626 mL | 0.9251 mL | 1.1564 mL |
100 mM | 0.0231 mL | 0.1156 mL | 0.2313 mL | 0.4626 mL | 0.5782 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Combretastatin A4
Catalog No.:BCC7089
CAS No.:117048-59-6
- Wulignan A1
Catalog No.:BCN5808
CAS No.:117047-76-4
- 3'-Methoxypuerarin
Catalog No.:BCN2900
CAS No.:117047-07-1
- Licopyranocoumarin
Catalog No.:BCN7900
CAS No.:117038-80-9
- Anwuweizonic acid
Catalog No.:BCN3633
CAS No.:117020-59-4
- Boc-Asp(Ofm)-OH
Catalog No.:BCC3366
CAS No.:117014-32-1
- Bis(2-ethylhexyl) phthalate
Catalog No.:BCN6054
CAS No.:117-81-7
- 2-Anthraquinonecarboxylic acid
Catalog No.:BCN3451
CAS No.:117-78-2
- 2-Amino-3-hydroxyanthraquinone
Catalog No.:BCC8527
CAS No.:117-77-1
- Quercetin
Catalog No.:BCN6049
CAS No.:117-39-5
- Dantron
Catalog No.:BCN6048
CAS No.:117-10-2
- Rubiadin
Catalog No.:BCN6047
CAS No.:117-02-2
- A 967079
Catalog No.:BCC7967
CAS No.:1170613-55-4
- Scutebarbatine C
Catalog No.:BCN2382
CAS No.:910099-75-1
- Fmoc-Thr(tBu)-OPfp
Catalog No.:BCC3553
CAS No.:117088-31-0
- Fmoc-N-Me-Thr(tBu)-OH
Catalog No.:BCC3354
CAS No.:117106-20-4
- Boc-Ala(3-pyridyl)-OH
Catalog No.:BCC3322
CAS No.:117142-26-4
- Sophoraisoflavone A
Catalog No.:BCN6826
CAS No.:117204-81-6
- M 1145
Catalog No.:BCC6053
CAS No.:1172089-00-7
- PI3Kγ inhibitor 1
Catalog No.:BCC4180
CAS No.:1172118-03-4
- HO-3867
Catalog No.:BCC5639
CAS No.:1172133-28-6
- Taxacin
Catalog No.:BCN6950
CAS No.:117229-54-6
- Soyasaponin Aa
Catalog No.:BCN2597
CAS No.:117230-33-8
- 8alpha-Hydroxylabda-13(16),14-dien-19-yl p-hydroxycinnamate
Catalog No.:BCN1609
CAS No.:117254-98-5
[Determination of five components in Pueraria labta decoction with reference extraction method].[Pubmed:23234135]
Zhongguo Zhong Yao Za Zhi. 2012 Aug;37(16):2388-91.
OBJECTIVE: To establish the reference extraction method for determining five components contained in Pueraria labta decoction and detecting the applicability and feasibility of the application of reference extracts according to the quality standard of traditional Chinese medicine. METHOD: Zorbax C18 chromatographic column (4.6 mm x 250 mm, 5 microm) was used, with methanol-0.02% phosphoric acid (25:75) as the mobile phase and the detection wavelength was set at 250 nm. Self-prepared reference extracts of P. labta was used for determining the content of 3'-hydroxy puerarin, puerarin, 3'-methoxy puerarin, isoflavoues aglycone-8-C-apiose-(1--> 6) glucoside and daidzin and compare with the experimental results obtained with the single reference substance determination method. RESULT: The reference extraction determination method showed high precision, stability and reproducibility, with coincident determination results with the results obtained with the single reference substance determination method. CONCLUSION: The reference extraction determination method of P. labta can be used for quality control of P. labta herbs. The study preliminarily proves the feasibility of the application of P. labta in traditional Chinese medicine.
Anti-inflammatory and antioxidant activities of constituents isolated from Pueraria lobata roots.[Pubmed:22644850]
Arch Pharm Res. 2012 May;35(5):823-37.
In order to evaluate the anti-inflammatory and antioxidant activities of Pueraria lobata roots and its active components, in vitro inhibitory activities against lipopolysaccharide (LPS)-induced nitric oxide (NO) production, inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2) protein expression, and tert-butylhydroperoxide (t-BHP)-induced reactive oxygen species (ROS) generation in RAW 264.7 cells, as well as in vitro scavenging activities against 1,1-diphenyl-2-picrylhydrazyl (DPPH), peroxynitrite (ONOO(-)), nitric oxide (NO.), superoxide anion (.O(2)(-)) and total ROS, and inhibitory activities against ONOO(-)-mediated tyrosine nitration, were determined. Repeated column chromatography was performed to isolate four known compounds from the anti-inflammatory and antioxidant EtOAc fraction: daidzein; genistein; puerarin; (+)-puerarol B-2-O-glucopyranoside; four known compounds from the anti-inflammatory n-hexane fraction: lupenone; lupeol; puerarol; coumestrol; seven known compounds from the antioxidant n-BuOH fraction: allantoin; 3'-hydroxypuerarin; daidzein 8-C-apiosyl-(1-->6)-glucoside; puerarin; genistin; 3'-methoxypuerarin; daidzin. Among these compounds, lupenone and lupeol reduced NO production, as well as iNOS and COX-2 protein levels in LPS-stimulated RAW 264.7 cells. Furthermore, lupeol showed significant inhibitory activity against intracellular ROS generation by t-BHP. Meanwhile, 3'-hydroxypuerarin showed marked ONOO(-), NO., total ROS scavenging activities, and weak .O(2)(-) scavenging activity, while 3'-methoxypuerarin showed ONOO(-) scavenging activity and weak NO. and O(2)(-) scavenging activities, suggesting that existence of the 3'-hydroxyl group in puerarin plays an important role in the scavenging of ONOO(-), NO., and total ROS, as well as inhibiting the ONOO(-)-mediated tyrosine nitration mechanism. These results indicate that P. lobata roots and its constituents may be a useful therapeutic and preventive approach to various inflammatory diseases and oxidative stress-related disease.
Qualitative and quantitative analysis of the major constituents in Chinese medicinal preparation Dan-Lou tablet by ultra high performance liquid chromatography/diode-array detector/quadrupole time-of-flight tandem mass spectrometry.[Pubmed:23518306]
J Pharm Biomed Anal. 2013 Jun;80:50-62.
A rapid ultra high performance liquid chromatography/diode-array detector/quadrupole time-of-flight tandem mass spectrometry (UPLC-DAD-QTOF) method and a ultra high performance liquid chromatography coupled with diode-array detector (UPLC-DAD) method were developed for qualitative and quantitative analyses of the major chemical constituents in Dan-Lou tablet. Sixty-eight compounds including flavonoids, phenolic acids, tanshinones, protostane triterpenoids, lactones, and paeoniflorins were unambiguously or tentatively identified by comparing their retention times and accurate mass measurement in 40min with references or literature data. Among them, 19 compounds: gallic acid, danshensu, 5-hydroxymethyl-2-furaldehyde, 3'-hydroxy puerarin, puerarin, 3'-methoxy puerarin, mirificin, daidzin, paeoniflorin, calycosin-7-O-beta-D-glucoside, naringin, genistin, rosmarinic acid, salvianolic acid B, salvianolic acid A, formononetin, calycosin, cryptotanshinone and tanshinone IIA were further quantified in 30min as marker substances. It was found that the calibration curves for all analytes showed good linearity (R(2)>0.9997) within the test ranges. The overall limits of detection (LODs) and limits of quantification (LOQs) were 0.0073-0.34mug/mL and 0.022-1.04mug/mL, respectively. The relative standard deviations (RSDs) for intra- and inter-day precisions were below 1.90% and 2.85%, respectively. The results of repeatability were less than 2.74%. The sample was stable for at least 48h. The mean recovery rates ranged from 95.5% to 105% with the relative standard deviations (RSDs) less than 2.96%. The results showed that the developed quantitative method was linear, sensitive, and precise for quality control of Dan-Lou tablet.